Vitamin D Deficiency Clinical Trial
Official title:
GraviD-child Follow-up of the Children´s Health, Growth and Development Within the GraviD-study
Verified date | September 2023 |
Source | Göteborg University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
GraviD is a multi-ethnic population-based pregnancy cohort. Pregnant women were invited to participate in the GraviD study when registering for antenatal care in parts of the region of Västra Götaland in Sweden in 2013-2014. All women registering for antenatal care were eligible for inclusion, as long as the pregnancy had not exceeded 16 gestational weeks. In total, 2125 pregnant women were recruited in gestational week 12 during two time-periods; fall 2013 and spring 2014. Blood sampling was performed in gestational week <17 and again at gestational week >31 by midwifes. After delivery, the maternity records were obtained, to collect information on child's gender, birth weight and length and other possible birth outcomes.
Status | Completed |
Enrollment | 172 |
Est. completion date | February 14, 2023 |
Est. primary completion date | January 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years to 9 Years |
Eligibility | Inclusion Criteria: - Born within the GraviD study - Healthy - Singleton Exclusion Criteria: - Chromosomal abnormality - Hyper-/Hypothyroidism |
Country | Name | City | State |
---|---|---|---|
Sweden | Queen Silvia Children's Hospital | Gothenburg |
Lead Sponsor | Collaborator |
---|---|
Göteborg University | Norwegian Institute of Public Health, Sahlgrenska University Hospital, Sweden |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body composition | Fat mass, derived from bioelectrical impedance, will be studied as percentage (%) of the total body weight. | At 7-9 years of age | |
Primary | Waist circumference | Measurements of waist circumference (in cm) will be assessed. | At 7-9 years of age | |
Primary | Blood pressure | Blood pressure in mm Hg will be assessed. | At 7-9 years of age | |
Primary | Blood lipids | Triglycerides in nmol/L will be assessed from a venous blood sample | At 7-9 years of age | |
Primary | Blood glucose | Glucose in mmol/L will be analyzed from a venous blood sample | At 7-9 years of age | |
Primary | Endothelial function | Endothelial function will be assessed as reactive hyperemia (RH)-index | At 7-9 years of age | |
Primary | Pulse wave velocity | Pulse wave velocity (neck to thigh) will be measured in meters per second | At 7-9 years of age | |
Primary | Ultrasound | Ultra-high frequency ultrasound of dorsalis pedis (in mm) will be measured | At 7-9 years of age | |
Primary | Ultrasound | Ultra-high frequency ultrasound of radialis (in mm) will be measured | At 7-9 years of age | |
Primary | Blood lipids | HDL-cholesterol in nmol/L will be assessed from a venous blood sample | At 7-9 years of age |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
Recruiting |
NCT05459298 -
ViDES Trial (Vitamin D Extra Supplementation)
|
N/A | |
Completed |
NCT04476511 -
The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules
|
Phase 3 | |
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT03920150 -
Vitamin D 24'000 IU for Oral Intermittent Supplementation
|
Phase 3 | |
Completed |
NCT03264625 -
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
|
Phase 2 | |
Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
Completed |
NCT05506696 -
Vitamin D Supplementation Study
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Completed |
NCT03234218 -
Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
|
||
Completed |
NCT03203382 -
Corneal Nerve Structure in Sjogren's
|
||
Completed |
NCT02714361 -
A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women
|
N/A | |
Completed |
NCT02906319 -
Vitamin D and HbA1c Levels in Diabetic Patients With CKD
|
N/A | |
Completed |
NCT02118129 -
Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'.
|
N/A | |
Not yet recruiting |
NCT01419821 -
Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5
|
N/A | |
Completed |
NCT02275650 -
The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter
|
N/A | |
Completed |
NCT02187146 -
The Effects of Serum Vitamin D and IVF Outcome
|
N/A | |
Completed |
NCT01688102 -
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
|
N/A | |
Completed |
NCT01651000 -
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
|
Phase 3 |